Group 1 - *ST Tianmao has voluntarily applied for termination of its stock listing, with the Shenzhen Stock Exchange deciding to delist the company effective September 25, 2025 [1][4] - The company primarily engages in insurance business through its subsidiaries, Guohua Life and Huarui Insurance, with insurance-related revenue accounting for 99.99% of its main business income [4] - The company announced its intention to withdraw its A-share listing in August 2025, citing significant uncertainties due to business restructuring [4] Group 2 - The company provided investors with a cash option for shares at a price of 1.60 CNY per share, with approximately 1.442 billion cash options effectively declared during the exercise period [5] - As of July 18, 2025, the company had 112,000 shareholders, and its last trading price before suspension was 1.58 CNY per share, giving it a market capitalization of approximately 7.7 billion CNY [5] - The stock will not enter a delisting adjustment period as per the Shenzhen Stock Exchange listing rules, meaning the delisting process will be immediate [4]

Core Points - GreenPower Motor Company Inc. has received a determination letter from Nasdaq stating it has not regained compliance with listing rules and faces potential delisting [1][2] - The company was notified on February 27, 2025, that its common shares had closed below US$1 for 30 consecutive business days, leading to a compliance deadline of August 26, 2025 [2] - The company is not eligible for a second compliance period due to not meeting the US$5,000,000 minimum stockholders' equity requirement [2] - On August 15, 2025, the company was informed of non-compliance with the Equity Rule and must submit a compliance plan by September 29, 2025 [3] - The company intends to appeal the determination, which will temporarily stay the suspension of its shares pending a decision [4] - If delisted, the company expects its shares to trade on OTC Markets and TSX Venture Exchange [5] Company Overview - GreenPower designs, builds, and distributes all-electric medium and heavy-duty vehicles, including transit buses and cargo vans [6] - The company employs a clean-sheet design for its vehicles, focusing on zero emissions and ease of maintenance [6] - Founded in Vancouver, Canada, GreenPower has primary operational facilities in southern California [6]

Core Viewpoint - *ST Tianmao (000627.SZ) announced its decision to voluntarily terminate its stock listing on the Shenzhen Stock Exchange and will apply to transfer to the National Equities Exchange and Quotations (NEEQ) after delisting [1] Group 1: Company Actions - The company convened its 10th Board of Directors' fourth meeting to approve the proposal for voluntary delisting [1] - The stock is set to resume trading on August 11, 2025, after the termination of its listing [1] Group 2: Financial Status and Risks - *ST Tianmao is currently facing a delisting crisis due to its failure to disclose the 2024 annual report and the 2025 Q1 report within the legal timeframe [4] - The company has not disclosed its financial reports as of August 6, 2024, and is working to complete the necessary documentation [4] - As of the end of Q3 2024, *ST Tianmao has over 120,000 shareholders [5] Group 3: Company Background - *ST Tianmao operates as an investment holding company primarily engaged in insurance business through its subsidiaries, Guohua Life and Huari Insurance [5] - Guohua Life, established in November 2007, has total assets of 271.599 billion and net assets of 26.22 billion as of June 2023 [5]

Core Viewpoint - Aura Minerals Inc. intends to voluntarily delist its common shares from the Toronto Stock Exchange (TSX) following its recent listing on Nasdaq, aiming to consolidate trading in the U.S. equity market and improve stock liquidity [1][2]. Group 1: Delisting Announcement - The company has completed its listing on Nasdaq on July 16, 2025, and is now pursuing the delisting from TSX [2]. - The delisting is subject to review and approval from TSX and the Comissão de Valores Mobiliários (CVM) in Brazil [1]. - The decision considers ongoing fees and expenses associated with maintaining a TSX listing and the availability of an alternative market on Nasdaq [2]. Group 2: Impact on Stakeholders - The change will not affect the rights of holders of Brazilian Depositary Receipts (BDRs) listed on B3, which will continue to be supported by common shares listed on Nasdaq, pending CVM approval [2]. - Aura emphasizes a holistic approach to mining, considering the impacts and benefits to all stakeholders, including shareholders, employees, and communities [3]. Group 3: Company Overview - Aura Minerals focuses on the development and operation of gold and base metal projects in the Americas, with five operating assets including gold and copper mines in Honduras, Brazil, and Mexico [4]. - The company also owns several gold projects in Guatemala, Colombia, and Brazil, with varying stages of development [4].

Core Viewpoint - Vincerx Pharma, Inc. is set to delist its common stock from Nasdaq due to non-compliance with listing rules, with trading suspended and plans for liquidation announced [2][3][4]. Group 1: Delisting and Trading Suspension - Vincerx received a delisting notice from Nasdaq on April 14, 2025, due to its common stock closing bid price being below the minimum requirement of $1.00 per share for 30 consecutive business days [2]. - Trading of Vincerx's common stock will be suspended at the opening of business on April 23, 2025, and the company intends to file a Form 25 Notification of Delisting with the SEC around April 28, 2025 [1][2]. - An inadvertent suspension of trading occurred on April 16, 2025, but trading will resume on April 21, 2025, until April 22, 2025 [4]. Group 2: Company Actions and Future Plans - The board of directors has decided to dissolve, liquidate, and wind up the company's affairs, distributing any remaining assets to stockholders after settling debts [3]. - Vincerx does not plan to appeal Nasdaq's determination and will not seek to list its common stock on another exchange [3]. - Following the effectiveness of Form 25, Vincerx will file a Form 15 to deregister with the SEC [4]. Group 3: Company Background - Vincerx Pharma, Inc. is a clinical-stage biopharmaceutical company based in San Mateo, California, with a research facility in Monheim, Germany [5].